Two Sigma Investments’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,516
| Closed | -$113K | – | 3175 |
|
|
2021
Q3 | $113K | Buy |
4,516
+1,903
| +73% | +$47.6K | ﹤0.01% | 2381 |
|
|
2021
Q2 | $165K | Sell |
2,613
-13,936
| -84% | -$880K | ﹤0.01% | 2259 |
|
|
2021
Q1 | $2.04M | Buy |
16,549
+3,719
| +29% | +$458K | 0.01% | 1260 |
|
|
2020
Q4 | $1.46M | Buy |
12,830
+8,316
| +184% | +$946K | ﹤0.01% | 1204 |
|
|
2020
Q3 | $540K | Sell |
4,514
-2,492
| -36% | -$298K | ﹤0.01% | 1385 |
|
|
2020
Q2 | $873K | Buy |
+7,006
| New | +$873K | ﹤0.01% | 1208 |
|
|
2019
Q3 | – | Sell |
-362
| Closed | -$156K | – | 2402 |
|
|
2019
Q2 | $156K | Buy |
362
+212
| +141% | +$91.4K | ﹤0.01% | 1891 |
|
|
2019
Q1 | $85K | Sell |
150
-429
| -74% | -$243K | ﹤0.01% | 2015 |
|
|
2018
Q4 | $172K | Sell |
579
-973
| -63% | -$289K | ﹤0.01% | 1892 |
|
|
2018
Q3 | $1.1M | Buy |
+1,552
| New | +$1.1M | ﹤0.01% | 1325 |
|